Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

More research is needed to understand how testosterone is maintained in adult males.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Suppressing certain hormones might help prevent prostate cancer.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.